THE RESILIENCE OF ONCOLOGISTS DURING THE EARLY TIME OF THE COVID-19 PANDEMIC
Angioletta Lasagna(University of Pavia), Paolo Pedrazzoli(Policlinico San Matteo Fondazione), Silvia Brugnatelli(Policlinico San Matteo Fondazione), Alessandra Ferrari(Ospedale Policlinico San Martino), Simona Secondino(Azienda Ospedaliera Treviglio), Silvia Chiellino, C. Gandini(Policlinico San Matteo Fondazione), Alessia Pagani(Vita-Salute San Raffaele University), Elisa Ferraris(Fondazione Salvatore Maugeri), Ilaria Imarisio(University of Pavia), Richard Tancredi(Istituti Ospitalieri di Cremona), Teresa Monaco(Istituti di Ricovero e Cura a Carattere Scientifico), Gianpiero Rizzo(Policlinico San Matteo Fondazione), E. Pozzi(Policlinico San Matteo Fondazione), Francesco Agustoni(University of Pavia)
Cited by 1
Related Papers
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378
Hepcidin and Anemia: A Tight Relationship
|Frontiers in Physiology|2019|246
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
|Cancer Discovery|2020|183
Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy
|Radiotherapy and Oncology|2017|173
Uncovering Pandora’s vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib
|Clinical and Experimental Medicine|2007|146